Carla P. Martins
Oncology R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome.
Journal: Nature aging
Published: January 17, 2025
A Simple Analysis of the Second (Extra) Disulfide Bridge of VHHs.
Journal: Molecules (Basel, Switzerland)
Published: July 30, 2024
Structural comparison of homologous protein-RNA interfaces reveals widespread overall conservation contrasted with versatility in polar contacts.
Journal: PLoS computational biology
Published: May 24, 2024
Associations between psychological distress in adolescence and menstrual symptoms across life: Longitudinal evidence from the 1970 British Cohort Study.
Journal: Journal of affective disorders
Published: November 20, 2023
Extended-depth of field random illumination microscopy, EDF-RIM, provides super-resolved projective imaging.
Journal: Light, science & applications
Published: October 30, 2023
Evaluation of the Potential Impact of In Silico Humanization on VHH Dynamics.
Journal: International journal of molecular sciences
Published: August 21, 2023
Prospective validation of an equation based on plasma cystatin C for monitoring the glomerular filtration rate in children treated with cisplatin or ifosfamide for cancer.
Journal: Cancer chemotherapy and pharmacology
Published: July 07, 2023
Towards Molecular Understanding of the Functional Role of UbiJ-UbiK2 Complex in Ubiquinone Biosynthesis by Multiscale Molecular Modelling Studies.
Journal: International journal of molecular sciences
Published: July 29, 2022
AZD4625 is a Potent and Selective Inhibitor of KRASG12C.
Journal: Molecular cancer therapeutics
Published: April 05, 2022
VHH Structural Modelling Approaches: A Critical Review.
Journal: International journal of molecular sciences
Published: February 25, 2022
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery.
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery.
Journal: Nature communications
Published: March 23, 2020
Last Updated: 09/26/2026